Cannon PM - Search Results

1

Reprogramming human B cells with custom heavy chain antibodies.

Rogers GL, Huang C, Mathur A, Huang X, Chen HY, Stanten K, Morales H, Chang CH, Kezirian EJ, Cannon PM. Rogers GL, et al. Among authors: cannon pm. bioRxiv [Preprint]. 2023 Jun 30:2023.06.28.546944. doi: 10.1101/2023.06.28.546944. bioRxiv. 2023. Update in: Nat Biomed Eng. 2024 Jul 22. doi: 10.1038/s41551-024-01240-4. PMID: 37425794 Free PMC article. Updated. Preprint.

2

SARS-CoV-2 Enters Human Leydig Cells and Affects Testosterone Production In Vitro.

Li L, Sottas CM, Chen HY, Li Y, Cui H, Villano JS, Mankowski JL, Cannon PM, Papadopoulos V. Li L, et al. Among authors: cannon pm. Cells. 2023 Apr 20;12(8):1198. doi: 10.3390/cells12081198. Cells. 2023. PMID: 37190107 Free PMC article.

3

Correction: Limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone repair applications.

Bougioukli S, Chateau M, Morales H, Vakhshori V, Sugiyama O, Oakes D, Longjohn D, Cannon P, Lieberman JR. Bougioukli S, et al. Gene Ther. 2024 Sep;31(9-10):527. doi: 10.1038/s41434-024-00472-y. Gene Ther. 2024. PMID: 39090205 No abstract available.

4

Reprogramming human B cells with custom heavy-chain antibodies.

Rogers GL, Huang C, Mathur A, Huang X, Chen HY, Stanten K, Morales H, Chang CH, Kezirian EJ, Cannon PM. Rogers GL, et al. Among authors: cannon pm. Nat Biomed Eng. 2024 Jul 22. doi: 10.1038/s41551-024-01240-4. Online ahead of print. Nat Biomed Eng. 2024. PMID: 39039240

5

Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.

Llewellyn GN, Chen HY, Rogers GL, Huang X, Sell PJ, Henley JE, Cannon PM. Llewellyn GN, et al. Among authors: cannon pm. J Virol. 2023 Aug 31;97(8):e0068423. doi: 10.1128/jvi.00684-23. Epub 2023 Aug 9. J Virol. 2023. PMID: 37555663 Free PMC article.

6

Reprogramming human B cells with custom heavy chain antibodies.

Rogers GL, Huang C, Mathur A, Huang X, Chen HY, Stanten K, Morales H, Chang CH, Kezirian EJ, Cannon PM. Rogers GL, et al. Among authors: cannon pm. Res Sq [Preprint]. 2023 Jul 17:rs.3.rs-3117686. doi: 10.21203/rs.3.rs-3117686/v1. Res Sq. 2023. Update in: Nat Biomed Eng. 2024 Jul 22. doi: 10.1038/s41551-024-01240-4. PMID: 37503066 Free PMC article. Updated. Preprint.

7

Knockdown of Astrocytic Monocarboxylate Transporter 4 in the Motor Cortex Leads to Loss of Dendritic Spines and a Deficit in Motor Learning.

Lundquist AJ, Llewellyn GN, Kishi SH, Jakowec NA, Cannon PM, Petzinger GM, Jakowec MW. Lundquist AJ, et al. Among authors: cannon pm. Mol Neurobiol. 2022 Feb;59(2):1002-1017. doi: 10.1007/s12035-021-02651-z. Epub 2021 Nov 25. Mol Neurobiol. 2022. PMID: 34822124

8

Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes.

Rogers GL, Huang C, Clark RDE, Seclén E, Chen HY, Cannon PM. Rogers GL, et al. Among authors: cannon pm. Mol Ther Methods Clin Dev. 2021 Sep 10;23:198-209. doi: 10.1016/j.omtm.2021.09.003. eCollection 2021 Dec 10. Mol Ther Methods Clin Dev. 2021. PMID: 34703842 Free PMC article.

9

The genome-editing decade.

Cannon PM, Kiem HP. Cannon PM, et al. Mol Ther. 2021 Nov 3;29(11):3093-3094. doi: 10.1016/j.ymthe.2021.10.016. Epub 2021 Oct 26. Mol Ther. 2021. PMID: 34699779 Free PMC article. No abstract available.

10

Genome edited B cells: a new frontier in immune cell therapies.

Rogers GL, Cannon PM. Rogers GL, et al. Among authors: cannon pm. Mol Ther. 2021 Nov 3;29(11):3192-3204. doi: 10.1016/j.ymthe.2021.09.019. Epub 2021 Sep 24. Mol Ther. 2021. PMID: 34563675 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page